Funding Announcements: National Institute of Neurological Disorders and Stroke (NINDS) Copyright 2014, National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov/funding/funding_announcements/RSS_Funding.htm en Funding Announcements Saturday Sunday http://blogs.law.harvard.edu/tech/rss NINDS Institutional Center Core Grants to Support Neuroscience Research (P30) http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-14-013 .htm http://www.ninds.nih.gov/funding/funding_announcements/rfa/RFA-NS-14-013 .htm This Funding Opportunity Announcement (FOA) invites applications for Center Core Grants that provide resources and facilities shared by a minimum of six NINDS-supported investigators, and supporting a wider base of neuroscience research. The proposed Centers should offer services and expertise that would be difficult or impractical to support in individual labs. The Centers are expected to capitalize on economies and synergies associated with shared resources, and to foster a collaborative environment among neuroscientists at host institutions. Tue, 14 Oct 2014 00:00:00 EDT Notice of Intent to Publish a Funding Opportunity Announcement for The NINDS Human Biomarkers Biospecimen Repository (U2C) http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-14-051.htm http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-14-051.htm The National Institute of Neurological Disorders and Stroke (NINDS) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for biospecimen banking and associated data management for biomarkers of neurological disorders. Fri, 10 Oct 2014 00:00:00 EDT Request for Information (RFI): B.R.A.I.N. Initiative Public/Private Partnership to Accelerate Clinical Access to Next-Generation Stimulating/Recording Devices http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-14-054.htm http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-14-054.htm The purpose of this time-sensitive RFI, issued by the Institutes of the NIH BRAIN Initiative (http://www.nih.gov/science/brain/funding.htm), is to seek input from interested academic/clinical researchers, regulatory and other government agencies, and potential industry partners to identify key barriers and potential opportunities to grant earlier broad access to significant risk recording and/or stimulating medical devices for clinical research. As the intent is to address the unique manufacturing and regulatory burden for SR implantable medical devices, the scope of the RFI is limited to invasive technologies that can stimulate and/or record from the brain, and for which first IDEs have already been obtained or could be obtained in the very near term. Fri, 26 Sep 2014 00:00:00 EDT Notice of Intent to Publish a Funding Opportunity Announcement for The NINDS Human Cell Resource and Repository (U42) http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-14-052.htm http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-14-052.htm The National Institute of Neurological Disorders and Stroke (NINDS) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications that will support the development of a human cell resource and repository focused on derivation, standardized quality assessment, biobanking, data management and distribution of human iPSC and fibroblast lines identified as unique and high value resources for the neuroscience community and for the study of neurological disorders. Thu, 25 Sep 2014 00:00:00 EDT Notice of Intent to Publish a Funding Opportunity Announcement for NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50) http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-14-053.htm http://www.ninds.nih.gov/funding/funding_announcements/notice/NOT-NS-14-053.htm The National Institute of Neurological Disorders and Stroke (NINDS) will continue the Morris K. Udall Centers of Excellence in Parkinson's Disease Research program by publishing a Funding Opportunity Announcement (FOA) for new and renewal applications. The purpose of this Notice is to alert potential applicants and to provide sufficient lead time for the development of responsive projects. This FOA will utilize the Specialized Center (P50) activity code, which will support a spectrum of basic, translational and clinical research activities utilizing an integrated, multidisciplinary approach to a specific disease entity, Parkinson's Disease (PD). It is anticipated that this FOA will be published in autumn 2014 with an expected application due date in winter of 2015. Thu, 25 Sep 2014 00:00:00 EDT High Throughput Screening (HTS) to Discover Chemical Probes (R01) http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-14-284 .htm http://www.ninds.nih.gov/funding/funding_announcements/pa/PAR-14-284 .htm Technological innovations in high throughput screening (HTS), chemical synthesis, and cheminformatics have allowed rapid discovery of novel, small-molecule probes for the study of disease related biological processes and mechanisms in academic environments (see Academic Screening Facilities Directory, http://www.slas.org/screeningFacilities/facilityList.cfm). This provides an unprecedented opportunity for investigators to translate knowledge about diseases into tangible tools for translational research. This Funding Opportunity Announcement (FOA) aims to support investigators to form collaborations with an academic, nonprofit, or commercial HTS screening facility that has the requisite expertise and experience to implement an HTS-ready assay for the discovery and development of small molecule chemical probes. Through this FOA, NIH wishes to stimulate research in 1) discovery and development of novel, small molecules for their potential use in studying disease treatments relevant to the missions of the participating NIH Institutes, and 2) discovery and/or validation of novel, biological targets that will inform studies of disease mechanisms. Emphasis will be placed on projects that provide new insight into important disease targets and processes. For example, applications may involve emerging therapeutic targets and mechanisms for the discovery of chemical probes that may lead to further development of therapeutics or provide insight into the biology of relevant diseases and health. Wed, 17 Sep 2014 00:00:00 EDT